Table III.

Analysis of miR-130a, miR-25 and miR-191* expression and survival time of patients with non-small cell lung cancer.

			95% CI of HR
Expression levels	Median survival time, months	HR	Lower	Upper	Chi-square	P-value
miR-130a
High	40	1.584	0.878	2.77	2.188	0.139
Low	58	0.631	0.361	1.14
miR-25
High	40	1.942	1.057	3.287	4.409	0.036a
Low	63	0.515	0.304	0.945
miR-191*
High	36	2.12	1.235	3.71	6.789	0.009b
Low	65	0.472	0.27	0.81

^aP<0.05

^bP<0.01. miR, microRNA; HR, hazard ratio.